Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Diana Parison"'
Autor:
Joëlle Bibeau, Erin Hillhouse, Catherine Beauchemin, K. Mathurin, Yasmine Rahal, Jean Lachaine, Diana Parison
Publikováno v:
Advances in Therapy
Introduction To save costs to the healthcare system, forced non-medical switch (NMS) policies that cut drug coverage for originator biologics and fund only less expensive biosimilars are being implemented. However, costs related to the impact of NMS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::442f0194632b371b35000655d12ef63a
https://pubmed.ncbi.nlm.nih.gov/34780028
https://pubmed.ncbi.nlm.nih.gov/34780028
Publikováno v:
Value in Health. 3(1):31-39
Objective To determine the cost-effectiveness of initiation of second-line hormone therapy with letrozole in the treatment of advanced breast cancer in postmenopausal women in Canada, compared to megestrol acetate. Methods A modified Markov model, in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::219cd298d5df6950fc3e9520ec5cbfc9
Autor:
Nicole Le Saux, Heather Onyett, Koravanagattu Sankaran, Sharon E. Moisiuk, John S. Sampalis, Avash J. Singh, Joan L. Robinson, Joanne M. Langley, Cecil Ojah, Lyne Frenette, Andrea F. Michaliszyn, Bosco Paes, Georges Caouette, Ian Mitchell, Marc H. Lebel, Hervé Walti, Diana Parison, Brian S. Simmons, Patricia Manzi, Upton Allen, Carina Majaesic, Godfrey S. Bacheyie, David S. C. Lee, Barbara J. Law, Karel O'Brien
Publikováno v:
The Pediatric infectious disease journal. 23(9)
Infants born at 33 through 35 completed weeks of gestation (33-35GA) are at risk for severe respiratory syncytial virus (RSV) infection, and palivizumab prophylaxis lowers hospitalizations for RSV infection by as much as 80%. The 33-35GA cohort compr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cac7708b2bd982e08c5cbe369d8ca2d4
https://pubmed.ncbi.nlm.nih.gov/15361719
https://pubmed.ncbi.nlm.nih.gov/15361719
Autor:
Alice Yoon, Krista L. Lanctôt, Diana Parison, Brian S. Simmons, Bosco Paes, Patricia Manzi, David S. C. Lee, Paul Oh
Publikováno v:
The Pediatric infectious disease journal. 21(6)
To provide information on the use and outcomes of palivizumab prophylaxis in children at high risk of serious respiratory syncytial virus (RSV) infection.Observational, prospective, longitudinal, multicenter study.Eighteen hospitals and pediatric cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b9a5f97a827d657267da7c8a041158c
https://pubmed.ncbi.nlm.nih.gov/12182374
https://pubmed.ncbi.nlm.nih.gov/12182374
Publikováno v:
The Canadian journal of urology. 5(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d8fcb1d84e9e4b8cb9e3d752859b9147
https://pubmed.ncbi.nlm.nih.gov/11319044
https://pubmed.ncbi.nlm.nih.gov/11319044